Combination Of First Component Of Sputnik V Vaccine With Vaccines By Astrazeneca, Sinopharm And Moderna Demonstrates High Safety Profile During The Study
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the initial safety results of the randomized, single-blind study for the evaluation of the immune response and safety of…
Share